Literature DB >> 6667397

Ultrastructural and purification studies on human tumor nucleolar antigens and nucleolar particles.

H Busch, R K Busch, P K Chan, Y C Choi, Y Daskal, N Domae, F Harmon, K Kobayashi, K Nohga, K Smetana.   

Abstract

The presence of common nucleolar antigens in a broad array of human malignant tumors has led to several lines of investigations. In addition to studies on an increasing number of benign and malignant neoplasms with a variety of antibodies designed to statistically evaluate the presence of nucleolar antigens, purification procedures and chemical analyses are being used to characterize the specific antigens. The localization of the nucleolar antigens in HeLa cells was studied by the postembedding immunoelectron microscopic procedure employing rabbit antibodies to nucleoli or nuclear Tris extracts of these cells. The products of the peroxidase-antiperoxidase complexes visualized by the reaction with diaminobenzidine in nucleoli were mainly found in the nucleolonemas which contain the dense nucleolar RNP components. When these nucleoli became compact after treatment of HeLa cells with adriamycin, the distribution of the immunoreactive products was altered along with distribution of the dense nucleolar components. The human nucleolar antigens were mainly localized to nucleolar regions containing the nucleolar RNP components. Improved purification of the antigens made it possible to provide a satisfactory amino acid analysis of one pI 6.3 antigen. Interestingly, some of the nucleolar antigen was found in miniparticle undescribed until now.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6667397     DOI: 10.3109/07357908309040930

Source DB:  PubMed          Journal:  Cancer Invest        ISSN: 0735-7907            Impact factor:   2.176


  1 in total

1.  Proliferating cell nuclear antigen (PCNA) and human malignant tumor nucleolar antigens (HMTNA) in nucleoli of human hematological malignancies.

Authors:  K Smetana; F Gyorkey; P K Chan; E Tan; H Busch
Journal:  Blut       Date:  1983-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.